Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2010-024138-43 | EudraCT Number |
Not provided
Not provided
Low recruitment rate
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Castilla-La Mancha | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In hypotensive septic patients with controlled source, an hemodynamic management protocol including hypertonic saline (HS)and terlipressin improves MOD (Multiple Organ Dysfunction) Score by at least 3 points compared to the use of physiologic saline and norepinephrine.
The appropriate design for this trial would be factorial. For the time being, will consider de intervention as a whole unit for this pilot study. In the future an appropriately sized factorial multicentric study shall be necessary.
Other goals of the pilot study:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Hypertonic Saline and Terlipressin | Experimental |
| |
| Normal Saline and norepinephrine | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hypertonic Saline and Terlipressin | Drug | Hypertonic saline 3% 7mL/Kg (with a maximum 500 mL)triggered by either Systolic Volume Variation or Pulse Pressure Variation more than 10%; Terlipressin infusion (dilution 1mg in 100mL) triggered by MAP below 70 mmHg for a goal MAP above 70 mmHg |
| Measure | Description | Time Frame |
|---|---|---|
| MOD (Multiple Organ Dysfunction) Score | daily, as long as the patient stays in the ICU |
| Measure | Description | Time Frame |
|---|---|---|
| Hypertonic Saline restores IV fluid response parameters (Pulse Pressure Variation or Systolic Volume Variation) adequately | First 48 hours | |
| Hypertonic Saline associated with terlipressin maintains plasma sodium levels 130-155mEq/L | As long as Hypertonic saline plus terlipressin are in use and one week later |
Not provided
Inclusion Criteria:
Criteria of SIRS: at least 2 of 4:
Septic source known demonstrated (or at least of high probability) and controlled (if it is controllable)
Hematocrit 25% or higher and/or hemoglobin 8 g/dL or higher. If necessary, transfuse RBCs to meet this criteria
MAP less than 70 mm Hg. Note there is no requirement for adequate preload evidence
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Javier Pascual RamÃrez | HGCR | Principal Investigator |
| Luis COLLAR VIÑUELAS, MD | HGCR | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital General de Ciudad Real | Ciudad Real | Ciudad Real | 13005 | Spain |
Not provided
| ID | Term |
|---|---|
| D012772 | Shock, Septic |
| ID | Term |
|---|---|
| D018805 | Sepsis |
| D007239 | Infections |
| D018746 | Systemic Inflammatory Response Syndrome |
| D007249 | Inflammation |
Not provided
Not provided
| ID | Term |
|---|---|
| D012462 | Saline Solution, Hypertonic |
| D000077585 | Terlipressin |
| D000077330 | Saline Solution |
| D009638 | Norepinephrine |
| ID | Term |
|---|---|
| D006982 | Hypertonic Solutions |
| D012996 | Solutions |
| D004364 | Pharmaceutical Preparations |
| D008236 | Lypressin |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Normal saline and norepinephrine | Drug | Normal saline IV bolus 7mL/kg (with a maximum 500 mL)triggered by either Systolic Volume Variation or Pulse Pressure Variation above 10%; Norepinephrine drip (80 micrograms/mL) to keep MAP at least 70 mmHg |
|
| There is an inverse relationship between plasma sodium and plasma procalcitonin levels measured by a negative Pearson coefficient | As long as the patient stays in the ICU |
| Hypertonic Saline associated with terlipressin normalizes blood pressure in septic shock | First 48 hours |
| Hypertonic Saline boluses increases plasma levels of vasopressin (AVP) | First week in ICU |
| Hypertonic Saline use rises levels of cortisol but not of adrenocorticotropic hormone (ACTH) | First week in ICU |
| D010335 |
| Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012769 | Shock |
| D014667 |
| Vasopressins |
| D010909 | Pituitary Hormones, Posterior |
| D010907 | Pituitary Hormones |
| D036361 | Peptide Hormones |
| D006728 | Hormones |
| D006730 | Hormones, Hormone Substitutes, and Hormone Antagonists |
| D009479 | Neuropeptides |
| D010455 | Peptides |
| D000602 | Amino Acids, Peptides, and Proteins |
| D009842 | Oligopeptides |
| D009419 | Nerve Tissue Proteins |
| D011506 | Proteins |
| D000077324 | Crystalloid Solutions |
| D007552 | Isotonic Solutions |
| D004983 | Ethanolamines |
| D000605 | Amino Alcohols |
| D000438 | Alcohols |
| D009930 | Organic Chemicals |
| D000588 | Amines |
| D015306 | Biogenic Monoamines |
| D001679 | Biogenic Amines |
| D002395 | Catecholamines |
| D002396 | Catechols |
| D010636 | Phenols |
| D001555 | Benzene Derivatives |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |